HEAL90
A Restorative health company with an addressable market of over 60M people, a unique business model, generating revenue, track record of success, and clear strategy to access its target market.
Our venture capital healthcare portfolio is a testament to our dedication to investing in transformative healthcare companies. Our portfolio consists of innovative opportunities consistent with our investment thesis.
Target Investment Profile
Size
$250K - $3M
​
Investments ranging from $250,000 to $3 million per deal, with an average investment of around $1 million.
Stage
MMC Ventures Fund’s preferred investment is early stage, where investment from MMC Ventures, and involvement from MMC and MMCV acquires a meaningful equity position and opportunity for significant ROI.
Specialty
In 2022, the healthcare industry accounted for 17.3% of the U.S. GDP, totaling $4.5 trillion. The industry has shown positive growth as it grew by 4.1% compared to 3.2% the previous year. This sector presents excellent opportunities for MMC to utilize its expertise and relationships.
To see our current investment criteria click here.
Portfolio Construction
Restorative Health
There is a rapidly growing demand for cutting-edge therapeutic evidence-based behavioral interventions that can prevent, treat, and manage chronic conditions such as cardiovascular diseases, Type 2 diabetes, and obesity.
​
Diagnostics
Diagnostic tests play a critical role in clinical decision-making, informing up to 70% of such decisions in healthcare.
However, traditionally only 2-5% of healthcare funding has been allocated for diagnostic procedures.
​
​
Healthcare Delivery & Support**
In 2022, the healthcare industry accounted for 17.3% of the U.S. GDP, totaling $4.5 trillion. The industry has shown positive growth as it grew by 4.1% compared to 3.2% the previous year. This sector presents excellent opportunities for MMC to utilize its expertise and relationships.
​
Health Technology^
The healthcare IT market hit
$663.0 billion in 2023 and is expected to grow at 15.8% annually from 2024 to 2030. Using advanced technologies is crucial to improve patient care and address the $500 billion spent yearly on low productivity and waste in healthcare.
​
​
​
​
Investment Portfolio Highlights
We are committed to discovering the most innovative healthcare companies and supporting their growth to drive positive change. If you share our passion for healthcare innovation and success, we would love to hear from you.
Diagnostics: Roche Diagram, “Breaking Silos to Unlock the Value of Diagnostics”, Edition 2017, Volume 2. (https://rochediagram.com/breaking-silos-to-unlock-the-value-of-diagnostics/)
**Healthcare Delivery: https://www.mckinsey.com/industries/healthcare/our-insights/investing-in-the-new-era-of-value-based-care
^ Why the evolving healthcare services and technology market matters https://www.mckinsey.com/industries/healthcare/our-insights/why-the-evolving-healthcare-services-and-technology-market-matters
Healthcare IT Market Size & Trends https://www.grandviewresearch.com/industry-analysis/healthcare-it
©2024 MMCV, Inc. All Rights Reserved